Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-35 |
filingDate |
2009-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20110044883-A |
titleOfInvention |
Novel Compositions and Methods |
abstract |
The present invention provides an antibody comprising (i) a Rv3616c protein sequence for use in the treatment or prevention of latent TB; (Ii) variants of the Rv3616c protein sequence; Or (iii) an immunogenic fragment of the Rv3616c protein sequence. In another aspect, the present invention relates to methods of treating or preventing related polynucleotides, fusion proteins, and latent tuberculosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940406-B2 |
priorityDate |
2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |